Cargando…
Whole-brain three-dimensional imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases
Autores principales: | Hansen, Henrik H., Roostalu, Urmas, Hecksher-Sørensen, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749470/ https://www.ncbi.nlm.nih.gov/pubmed/32594044 http://dx.doi.org/10.4103/1673-5374.284983 |
Ejemplares similares
-
Whole-brain activation signatures of weight-lowering drugs
por: Hansen, Henrik H., et al.
Publicado: (2021) -
3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II
por: Roostalu, Urmas, et al.
Publicado: (2020) -
Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease
por: Roostalu, Urmas, et al.
Publicado: (2019) -
An Optimized Mouse Brain Atlas for Automated Mapping and Quantification of Neuronal Activity Using iDISCO+ and Light Sheet Fluorescence Microscopy
por: Perens, Johanna, et al.
Publicado: (2020) -
Digital Brain Maps and Virtual Neuroscience: An Emerging Role for Light-Sheet Fluorescence Microscopy in Drug Development
por: Perens, Johanna, et al.
Publicado: (2022)